A flow cytometry-based method for detecting antibody responses to murine cytomegalovirus infection

Journal of Virological Methods

Volumn 142, Issue 1-2, 2007, Pages 50-58

  Bickerstaff, Alice A ^a   Zimmerman, Peter D ^a   Wing, Bret A ^a   Taylor, Frederick ^a   Trgovcich, Joanne ^a   Cook, Charles H ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Antibody; CMV; Flow cytometry; Murine cytomegalovirus

Indexed keywords

GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; KINETICS; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; VIRUS RESISTANCE;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HERPESVIRIDAE INFECTIONS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUROMEGALOVIRUS; NIH 3T3 CELLS; SENSITIVITY AND SPECIFICITY;

MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1; MURINAE; MUS;

EID: 34247119192     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.01.006     Document Type: Article

References (55)

1. Anderson C.A., Murphy J.C., and Fox J.G. Evaluation of murine cytomegalovirus antibody detection by serological techniques. J. Clin. Microbiol. 18 (1983) 753-758
2. Anderson C.A., Murphy J.C., and Fox J.G. Surveillance of mice for antibodies to murine cytomegalovirus. J. Clin. Microbiol. 23 (1986) 1152-1154
3. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 (2002) 1323-1326
4. Araullo-Cruz T.P., Ho M., and Armstrong J.A. Protective effect of early serum from mice after cytomegalovirus infection. Infect. Immun. 21 (1978) 840-842
5. Balthesen M., Messerle M., and Reddehase M.J. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67 (1993) 5360-5366
6. Bevan I.S., Sammons C.C., and Sweet C. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction. J. Med. Virol. 48 (1996) 308-320
7. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R.C., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., and Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292 (2001) 934-937
8. Bubic I., Wagner M., Krmpoti A., Saulig T., Kim S., Yokoyama W.M., Jonji S., and Koszinowski U.H. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78 (2004) 7536-7544
9. Castellano G.A., Hazzard G.T., Madden D.L., and Sever J.L. Comparison of the enzyme-linked immunosorbent assay and the indirect hemagglutination test for detection of antibody to cytomegalovirus. J. Infect. Dis. 136 Suppl. (1977) S337-S340
10. Chalmer J.E., Mackenzie J.S., and Stanley N.F. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J. Gen. Virol. 37 (1977) 107-114
11. Classen D.C., Morningstar J.M., and Shanley J.D. Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays. J. Clin. Microbiol. 25 (1987) 600-604
12. Collins T., Pomeroy C., and Jordan M.C. Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168 (1993) 725-729
13. Cook C., Zhang X., McGuinness B., Lahm M., Sedmak D., and Ferguson R. Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J. Infect. Dis. 185 (2002) 1395-1400
14. Cook C.H., Martin L.C., Yenchar J.K., Lahm M.C., McGuinness B., Davies E.A., and Ferguson R.M. Occult herpes family viral infections are endemic in critically ill surgical patients. Crit. Care Med. 31 (2003) 1923-1929
15. Cook C.H., Yenchar J.K., Kraner T.O., Davies E.A., and Ferguson R.M. Occult herpes family viruses may increase mortality in critically ill surgical patients. Am. J. Surg. 176 (1998) 357-360
16. Crnkovic-Mertens I., Messerle M., Milotic I., Szepan U., Kucic N., Krmpotic A., Jonjic S., and Koszinowski U.H. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J. Virol. 72 (1998) 1377-1382
17. Curtsinger L.J., Cheadle W.G., Hershman M.J., Cost K., Polk J., and Hiram C. Association of cytomegalovirus infection with increased morbidity is independent of transfusion. Am. J. Surg. 158 (1989) 606-611
18. Cushing D., Elliot S., Caplan E., Batlas S., Sridhara R., and Wade J. Herpes simplex virus and cytomegalovirus excretion associated with increased ventilator days in trauma patients. J. Trauma 25 (1993) 161
19. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., and Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2 (2001) 951-956
20. Farrell H.E., and Shellam G.R. Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice. J. Gen. Virol. 70 (1989) 2573-2586
21. Farrell H.E., and Shellam G.R. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. J. Gen. Virol. 72 (1991) 149-156
22. Furrarah A.M., and Sweet C. Studies of the pathogenesis of wild-type virus and six temperature-sensitive mutants of mouse cytomegalovirus. J. Med. Virol. 43 (1994) 317-330
23. Gonczol E., Danczig E., Boldogh I., Toth T., and Vaczi L. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection. Acta Microbiol. Hungarica 32 (1985) 39-47
24. Grundy J.E., Mackenzie J.S., and Stanley N.F. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 32 (1981) 277-286
25. Heininger A., Jahn G., Engel C., Notheisen T., Unertl K., and Hamprecht K. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit. Care Med. 29 (2001) 541-547
26. Heininger A., Vogel U., Aepinus C., and Hamprecht K. Disseminated fatal human cytomegalovirus disease after severe trauma. Crit. Care Med. 28 (2000) 563-566
27. Henry S.C., Schmader K., Brown T.T., Miller S.E., Howell D.N., Daley G.G., and Hamilton J.D. Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J. Virol. Methods 89 (2000) 61-73
28. Henson D., Smith R.D., and Gehrke J. Non-fatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations. Am. J. Pathol. 49 (1966) 871-888
29. Holtappels R., Grzimek N.K.A., Simon C.O., Thomas D., Dreis D., and Reddehase M.J. Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J. Virol. 76 (2002) 6044-6053
30. Jaber, S., Chanques, G., Borry, J., Souche, B., Verdier, R., Perrigault, P.-F., Eledjam, J.-J., 2005. Cytomegalovirus infection in critically ill patients: associated factors and consequences 10.1378/chest.127.1.233. Chest 127, 233-241.
31. Jonjic S., Pavic I., Polic B., Crnkovic I., Lucin P., and Koszinowski U.H. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179 (1994) 1713-1717
32. Karupiah G., Sacks T.E., Klinman D.M., Fredrickson T.N., Hartley J.W., Chen J.H., and Morse III H.C. Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4 + T cells and CD40. Virology 240 (1998) 12-26
33. Kettering J.D., Schmidt N.J., Gallo D., and Lennette E.H. Anti-complement immunofluorescence test for antibodies to human cytomegalovirus. J. Clin. Microbiol. 6 (1977) 627-632
34. Kurz S., Steffens H.P., Mayer A., Harris J.R., and Reddehase M.J. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71 (1997) 2980-2987
35. Kurz S.K., Rapp M., Steffens H.P., Grzimek N.K., Schmalz S., and Reddehase M.J. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 73 (1999) 482-494
36. Lawson C.M., Grundy J.E., and Shellam G.R. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J. Gen. Virol. 69 (1988) 1987-1998
37. Loh L.C., Balachandran N., and Britt W.J. Characterization of a membrane-associated phosphoprotein of murine cytomegalovirus (pp50) and its immunological cross-reactivity with a human cytomegalovirus protein. Virology 183 (1991) 181-194
38. Lussier G., Guenette D., and Descoteaux J.P. Comparison of serological tests for the detection of antibody to natural and experimental murine cytomegalovirus. Can. J. Vet. Res. 51 (1987) 249-252
39. Papazian L., Fraisse A., Garbe L., Zandotti C., Thomas P., Saux P., Pierrin G., and Gouin F. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 84 (1996) 280-287
40. Pelletier R.P., Hennessy P.K., Adams P.W., VanBuskirk A.M., Ferguson R.M., and Orosz C.G. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am. J. Transplant. 2 (2002) 134-141
41. Pereira L., Hoffman M., Gallo D., and Cremer N. Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect. Immun. 36 (1982) 924-932
42. Rodriguez M., Sabastian P., Clark P., and Brown M.G. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White Mice. J. Immunol. 173 (2004) 6312-6318
43. Scalzo A.A., Fitzgerald N.A., Simmons A., La Vista A.B., and Shellam G.R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171 (1990) 1469-1483
44. Selgrade M.K., Huang Y.S., Graham J.A., Huang C.H., and Hu P.C. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection. J. Immunol. 131 (1983) 3032-3035
45. Shanley J.D., Jordan M.C., and Stevens J.G. Modification by adoptive humoral immunity of murine cytomegalovirus infection. J. Infect. Dis. 143 (1981) 231-237
46. Simmons R.L., Matas A.J., Rattazzi L.C., Balfour Jr. H.H., Howard J.R., and Najarian J.S. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 82 (1977) 537-546
47. Smith H.R.C., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., Scalzo A.A., Fremont D.H., and Yokoyama W.M. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. PNAS 99 (2002) 8826-8831
48. Spector S.A., Wong R., Hsia K., Pilcher M., and Stempien M.J. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J. Clin. Invest. 101 (1998) 497-502
49. Stavnezer J. Antibody class switching. Adv. Immunol. 61 (1996) 79-146
50. Stinski M.F., Mocarski E.S., Thomsen D.R., and Urbanowski M.L. Membrane glycoproteins and antigens induced by human cytomegalovirus. J. Gen. Virol. 43 (1979) 119-129
51. Sullivan-Tailyour G., and Garnett H.M. Plasma membrane proteins and glycoproteins induced by human cytomegalovirus infection of human embryonic fibroblasts. J. Gen. Virol. 67 (1986) 515-526
52. Thale R., Lucin P., Schneider K., Eggers M., and Koszinowski U.H. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 68 (1994) 7757-7765
53. Tripathy S.K., Smith H.R.C., Holroyd E.A., Pingel J.T., and Yokoyama W.M. Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility Class I (MHC-I)-like protein is independent of viral regulation of host MHC-I. J. Virol. 80 (2006) 545-550
54. VanBuskirk A.M., Wakely M.E., Sirak J.H., and Orosz C.G. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation 65 (1998) 1115-1123
55. Voigt V., Forbes C.A., Tonkin J.N., Degli-Esposti M.A., Smith H.R.C., Yokoyama W.M., and Scalzo A.A. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. PNAS 100 (2003) 13483-13488